Connection
Eric Wu to Delayed-Action Preparations
This is a "connection" page, showing publications Eric Wu has written about Delayed-Action Preparations.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.179 |
|
|
|
-
Signorovitch J, Erder MH, Xie J, Sikirica V, Lu M, Hodgkins PS, Wu EQ. Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:130-7.
Score: 0.086
-
Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies. J Manag Care Pharm. 2007 Sep; 13(7):561-9.
Score: 0.062
-
Guo A, Niyazov A, Macaulay D, Terasawa E, Schmerold L, Wu EQ, Krieger S. Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database Analysis. J Manag Care Spec Pharm. 2017 Jul; 23(7):771-780.
Score: 0.031